Malignant Neoplasm: Clinical Trials

2 trials for Malignant Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 active not recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Active not recruiting 2

Follow Malignant Neoplasm: new trials by email Literature Review of Malignant Neoplasm trials Research Report on Malignant Neoplasm

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dexamethasone in Controlling Dyspnea in Patients With Cancer
Dexamethasone, Placebo, Questionnaire Administration - Dyspnea, Malignant Neoplasm
Phase 2Active not recruitingM.D. Anderson Cancer Center1352017-12-042026-10-16
Gene and Vaccine Therapy in Treating Patients With Advanced Malignancies
aldesleukin, fludarabine phosphate, cyclophosphamide - Malignant Neoplasm
Phase 2Active not recruitingJonsson Comprehensive Cancer Center62012-11-022025-11-24

Narrower conditions

Neoplasms (2)  ·  Dyspnea (1)

Broader conditions

Pathological Conditions, Signs and Symptoms (1)  ·  Respiration Disorders (1)  ·  Respiratory Tract Diseases (1)  ·  Signs and Symptoms (1)  ·  Signs and Symptoms, Respiratory (1)

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  Calcium Dobesilate (1)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Interleukin-2 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  aldesleukin (1)  ·  auricularum (1)  ·  dexamethasone 21-phosphate (1)  ·  dexamethasone acetate (1)  ·  fludarabine phosphate (1)

Sponsors

Jonsson Comprehensive Cancer Center (1)  ·  M.D. Anderson Cancer Center (1)

Countries

United States (2)

Top investigators

Antonio Ribas, MD, PhD (1)  ·  David Hui (1)

Results publications

PMID 30573690, PMID 36087590, PMID 42018190